Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 4 SUPPL., 1998, Pages

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Airway hyperresponsiveness; Asthma; Inflammation; Inhaled corticosteroids; Side effects

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; NEDOCROMIL SODIUM; THEOPHYLLINE;

ASTHMA; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; HUMANS; STEROIDS;

EID: 0031957295     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70154-X     Document Type: Article

References (61)

1. Barnes PJ. Anti-inflammatory therapy in asthma. Annu Rev Med 1993;44:229-49.
2. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-75.
3. Barnes PJ. Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 1994;150:S42-9.
4. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
5. Knox AJ. Airway re-modelling in asthma: role of airway smooth muscle. Clin Sci 1994;86:647-52.
6. Pizzichini E, Pizzichini M, Efthimiadis A, Evans S, Morris MM, Squillance D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
7. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.
8. Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax 1996;51:218-20.
9. Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LDR, et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 1994;203:209-18.
10. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
11. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
12. Kharitonov S, Chung KF, Evans DJ, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is derived from the lower repiratory tract. Am J Respir Crit Care Med 1996;153:1773-80.
13. Barnes PJ. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 1996;97:159-68.
14. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ. Glucocorticoid receptor localization in normal human lung and asthmatic lung. Am J Respir Crit Care Med 1996;154:771-82.
15. Barnes PJ, Adcock IM. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-41.
16. Barnes PJ, Adcock IM. Transcription factors in asthma. Clin Exp Allergy 1995;27(suppl 2):46-9.
17. Kharitonov SA, Yates DH, Barnes PJ. Regular inhaled budesonide decreases nitric oxide concentration in the exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-7.
18. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur J Respir Dis 1996;9:196-201.
19. Schleimer RP. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic application in asthma. Am Rev Respir Dis 1990;141:S59-69.
20. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 1992;90:32-42.
21. Djukanovic R, Wilson JW, Britten YM, Wilson SJ, Walls AF, Roche WF, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma. Am Rev Respir Dis 1992;145:699-74.
22. Jeffery PK, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson S. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992;145:890-9.
23. Burke C, Power CK, Norris A, Condez A, Schmekel B, Poulter LW. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 1992;5:73-9.
24. Trigg CJ, Manolistas ND, Wang J, Calderon MA, McAvlay A, Jordan SE, et al. Placebo-controlled immunopathological study of four months inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22.
25. Barnes PJ. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis 1990;141:S70-6.
26. Bel EH, Timers MC, Zwinderman AH, Dijkman JH, Sterk PJ. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine. Am Rev Respir Dis 1991;143:109-13.
27. Barnes PJ, Pedersen S. Efficacy and safety of inhaled steroids in asthma. Am Rev Respir Dis 1993;148:51-26.
28. Konig P. Inhaled corticosteroids - their present and future role in the management of asthma. J Allergy Clin Immunol 1988;82:297-306.
29. Barnes PJ. A new approach to asthma therapy. N Engl J Med 1989;321:1517-27.
30. Sheffer AL. National Heart Lung and Blood Institute National Asthma Education Programme Expert Panel Report: guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991;88:425-534.
31. Sheffer AL. International consensus report on diagnosis and management of asthma. Clin Exp Allergy 1992;22(suppl 1):1-72.
32. British Thoracic Society. Guidelines on the management of asthma. Thorax 1993;48(suppl):S1-24.
33. 2-agonist terbutaline with an inhaled steroid in newly detected asthma. N Engl J Med 1991;325:388-92.
34. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832-6.
35. Kerrebijn KF, Van Essen-Zandvliet EEM, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on bronchial responsiveness in asthmatic children. J Allergy Clin Immunol 1987;79:653-9.
36. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991;143:1317-21.
37. Juniper EF, Kline PA, Vanzielegmen MA, Hargreave FE. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991;87:483-9.
38. 2-agonists on lung function airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992;146:547-54.
39. Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, et al. Cessation of long-term treatment with inhaled corticosteroids (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis 1993;148:1252-7.
40. Dompeling E, Van Schayck CP, Molema J, Folgering Van Grusven PM, Van Weel C. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992;5:945-52.
41. Haahtela T, Järvinsen M, Kava T, Kirivanta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
42. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;5:369-72.
43. Selroos O, Pretnalcho A, Lofroos AB, Riska A. Effect of early and late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
44. Kamada AK, Szefler SJ, Martin RJ, Booshey HA, Chinchilli VM, Druzen JM, et al. Issues in the use of inhaled steroids. Am J Respir Crit Care Med 1996;153:1739-48.
45. Brattsand R, Axelsson B. New inhaled glucocorticosteroids. In: Barnes PJ, editor. New drugs for asthma. Vol. 2. London: IBC Technical Services; 1992:192-207.
46. Thomson NC. Nedocromil sodium: an overview. Respir Med 1989;83:269-76.
47. Manoliitsas ND, Wang J, Devalia J, Trigg CJ, McAuley AE, Davies RJ. Regular albuterol, nedocromil sodium and bronchial inflammation in asthma. Am J Respir Crit Care Med 1995;152:1925-30.
48. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus high-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
49. Woolcock A, Lundback B, Ringdal N, Jacques L. Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-8.
50. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64-77.
51. Barnes PJ, Thomson NC. Neural and humoral control. In: Barnes PJ, Rodger IW, Thomson NC, editors. Asthma: basic mechanisms and clinical management. London: Academic Press; 1992. p. 343-58.
52. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-14.
53. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. Low dose inhaled steroid plus theophylline vs high dose inhaled steroid in the control of asthma. N Engl J Med 1997;337:1412-8.
54. Chung KF. Leukotriene receptor antagonists and biosynthesis inhib-itors: potential breakthrough in asthma therapy. Eur Respir J 1995;8:1203-13.
55. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-9.
56. Bosley CM, Parry OT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J 1994;7:504-9.
57. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP, et al. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. Respir Med 1994;88:293-9.
58. Hummel S, Lehtonen L. Comparison of oral steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 1992;340:1483-7.
59. Dahl R, Lundbacr B, Malo J, Mazza JA, Nieminen MM, Saarglainen P. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352-8.
60. Barnes PJ. Inhaled glucocorticoids: new developments relevant to updating the Asthma Management Guidelines. Respir Med 1996;90:379-84.
61. British Thoracic Society. The British guidelines on asthma management. Thorax 1997;52(suppl 1):S1-21.